MedTrace Logo

Pregnancy in Osteogenesis Imperfecta (OI) Registry

NCT03072303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2019-10-16

No results posted yet for this study

Summary

The purpose of this study is to learn about pregnancy outcomes in osteogenesis imperfecta (OI). Patients enrolled in the Brittle Bone Disorders (BBD) Contact Registry (CR) will be invited via email to participate in this study.

Conditions

Interventions

OTHER

Web-based Survey

Patients will be sent an email invitation describing the study. If the participant wants to participate and is eligible, she will follow the survey link in the email message, which directs her to an IRB-approved online consent form. A unique survey link will be generated for each participant and included in the survey invitation, which is a customized email message. This link will allow the investigators to determine who completed the survey. The investigators will send repeat email invitations every two months (total of 3 invitations) to those invitees who have not yet participated. The investigators will allow approximately 6 months for enrollment and survey completion and expect that the study will close soon thereafter.

Sponsors & Collaborators

  • Rare Diseases Clinical Research Network

    collaborator NETWORK

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of South Florida

    lead OTHER

Principal Investigators

  • Jeffrey Krischer, Ph.D. · University of South Florida

  • Deborah Krakow, M.D. · University of California, Los Angeles

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-16
Primary Completion
2019-03-13
Completion
2019-09-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03072303 on ClinicalTrials.gov